Jasper Bos, Ph.D.

Jasper Bos, Ph.D., serves as a member of Braveheart Bio’s board of directors. Dr. Bos is currently a General Partner at Forbion Growth, a global venture capital firm investing in biotech companies, and previously served as the Chief Executive Officer of Forbion European Acquisitions Corporation (previously, Nasdaq: FRBN). Before joining Forbion, Dr. Bos was Senior Vice President and Managing Director at M Ventures, leading the venture capital arm of pharmaceutical company Merck & Co., Inc. (NYSE: MRK).

‍

Dr. Bos has experience in several operational roles in portfolio companies and played a key role in the creation of multiple successful spin-out companies out of Merck. Dr. Bos holds a Ph.D. in Pharmacy from the University of Groningen, the Netherlands.